A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports
Multisystem inflammatory syndrome in children is a newly described condition temporarily associated with severe acute respiratory syndrome coronavirus 2. The primary observations indicated coronavirus disease 2019 infection in children to be mild. However, recent reports have revealed a correlation...
Guardado en:
Autores principales: | Agnieszka Poniecka, Elżbieta Smolewska |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/beaf766e0d884c32839a66f37c38738a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?
por: Reiner Buchhorn, et al.
Publicado: (2021) -
Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later
por: Megan Striha, et al.
Publicado: (2021) -
An Arab Adolescent with Multisystem Inflammatory Syndrome Associated with COVID-19: A Report from Syria
por: Jaafer Zaino, et al.
Publicado: (2021) -
Paediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Infection: A Case Series
por: Aneesha Mathew, et al.
Publicado: (2021) -
Oral lesions in paediatric patients with COVID-19 and Paediatric Inflammatory Multisystem Syndrome: a review
por: Khaleda Zaheer, et al.
Publicado: (2022)